$3363
相关推文
按时间倒序
-
认为稳懋3105将成为激光扩产瓶颈，并提到顺欣、上诠、MSSCorp。
Win Semi（3105）几乎从不出现在光子学分析师报告中。 但明年它们很可能会作为激光器扩产的重要瓶颈出现。 很高兴看到我的台湾多头里，Shunsin（6451）开始起势。 Foci（3363）、MSSCorp（6830）也应该开始得到……
英文原文
Win Semi (3105) is almost never mentioned in photonics analyst reports. But they’ll probably show up as an important bottleneck for scaling lasers next year. Glad to see Shunsin (6451) start picking up steam from my TW longs. Foci (3363), MSSCorp (6830) should start getting https://t.co/BOYJl4tiTq
-
UDN报道TSM COUPE和AI光学市场，Foci和MSSCorp可能受益。
看，一篇新的 UDN 文章谈 $TSM COUPE + AI 光学市场。 机构投资者看好台湾公司： FOCI（3363）和 MSSCorps（6830）预计受益。 不过……这个“机构”是不是应该改成 X 上的散户投资者？ 关于 FOCI：“其 FAU 产品至少已与台积电合作开发三年，规格已推进到1.6T、3.2T，后续量产日程成为市场观察重点。” 关于 MSS：“切入硅光子和 CPO 检测分析，主打‘光损耗检测’技术……并推出硅光子测试平台，锁定研发、工程验证、失效分析和少量多样化测试应用。” 这仍然是两家极小的公司……像 MSS 这样的名字甚至没有被高盛提到，尽管新闻声称有相关性。 所以感觉是 X 很早发现了这个，主流机构看到这类确认后可能即将进入。
英文原文
Oh look, a new UDN article about $TSM COUPE + AI optical markets. Institutional investors are optimistic that Taiwanese companies: FOCI (3363), and MSScorps (6830) are expected to benefit But... that "Institutional" should be changed to retail investors on X? For FOCI: "Its FAU products have been developed in cooperation with TSMC for at least three years, and the specifications have been promoted to 1.6T, 3.2T, and the subsequent mass production schedule has become the focus of market observation." For MSS: "cut into the silicon photonics and CPO detection analysis, the main "light loss detection" technology ... and launch of the silicon photonics test platform, lock in research and development, engineering verification, failure analysis and a small number of diverse test applications." These are still two extremely small companies... and things like MSS weren't even mentioned by GS, despite the news claims about relations. So feels like X found this early, mainstream institutions are likely about to enter after seeing this sort of confirmation.
-
CPO市场将从零增长至910亿美元，欧洲、台湾、日本新玩家将主导CPO供应链变革。
人们好奇我为什么最近在关注非美国市场。 为什么？因为共封装光学(CPO)是我排名第一的主题性看多方向。 市场尚未意识到，光子学领域正经历一场突如其来的范式转变... 2025年，我是少数几个提前预判当前超级周期的人之一，当时买入的$AAOI约在$30、$LITE约在$300多、$AXTI约在$13...这些都是基于真实的业绩验证和其他人无法展示的thesis。 CPO市场将从约0增长到910亿美元的TAM机会。 高盛研究预计在未来1.5年内实现。 与此同时，整体光学市场将达到1540亿美元。 许多之前对当前光子学周期几乎没有任何敞口的企业： -> 欧洲企业拥有高端激光设计，如$SIVE或$SOI涉及衬底 -> 台湾企业如Foci (3363)、Nextronics (8147)、Shunsin (6451)等提供光学元件和代工服务 -> 日本企业涉及激光量产、衬底和化学品 突然之间成为了CPO的新主导力量。 至于美国玩家，目前敞口不大。但现有企业如$LITE、$COHR仍能从CPO中获得上涨空间，因为这是它们新的增长向量。 我对现有玩家的逆向思考： 他们的大部分估值已经反映了巨大的传统可插拔光学收入，而这些收入将不可避免地随时间被 cannibalize（ cannibalization蚕食），因此除非有人能利用杠杆，否则重新估值的空间有限。 许多新的纯CPO概念股会在H2 2026开始量产时从0到100极速增长（作为收入桥梁），然后进入H2 2027的规模化增长阶段（成为大规模增长驱动力）。 市场通常会在事件发生前8-12个月定价... 尽管在此期间市场可能出现波动，但我对自己的供应链研究在主题性方向上有高度信心。
英文原文
People wonder why I'm focusing on non-US markets recently. Why? CPO is my #1 thematic long. Markets don't know yet, the sudden paradigm shift in photonics... I was one of the only to frontrun the current supercycle in 2025 w/ $AAOI @ ~$30, $LITE ~$300s, and $AXTI at ~$13 on X.... With the actual receipts and thesis that others can't show. CPO goes from ~$0. To $91 Billion TAM opportunity. In the next 1 1/2 years from GS research. While overall optical market reaches $154B. Many players that had little exposure to the current photonics cycle at all: -> In Europe with high-end lasers design like $SIVE or $SOI with substrates. -> In Taiwan with Foci (3363), Nextronics (8147), Shunsin (6451) and others for optical components and foundries. -> In Japan with laser mass production, substrates, and chemicals. Are suddenly the new dominant players for CPO. As for US players, there's not much exposure. But the existing ones like $LITE, $COHR still get upside from CPO as that's their new growth vector. My contrarian thought process on current players: Is that most of their valuation is priced in huge legacy pluggable revenue that will inevitably face cannibalization over time, so re-rating potential is less unless someone uses leverage. A lot of these new purer play CPO names go from 0 to 100 extremely quickly one mass production starts H2 2026 for scale out (as a revenue bridge) into H2 2027 for scale up (massive growth driver). Markets usually price things in 8-12 months ahead of time too... I have high conviction thematically in my supply chain research despite any market volatility leading up until then.
-
列出自己喜欢的一串 CPO 相关名字
和 CPO 相关、我喜欢的一些名字： - $SIVE - Foci (3363) - $TSEM - Browave (3163) - PCL (4977) - $AXTI - Msscorps (6830) - $IQE - Shunsin (6451) - Furukawa Electric (5801) - $MTSI - Nextronics (8417) - $LITE - $COHR - FitTech (6706) - $GFS - $ASX - LandMark (3081) - $SOI 披露一下：我大多都持有，但不是全部。
英文原文
Random CPO related names I like: - $SIVE - Foci (3363) - $TSEM - Browave (3163) - PCL (4977) - $AXTI - Msscorps (6830) - $IQE - Shunsin (6451) - Furukawa Electric (5801) - $MTSI - Nextronics (8417) - $LITE - $COHR - FitTech (6706) - $GFS - $ASX - LandMark (3081) - $SOI Disclosure: I own most, not all though.
-
列举一组光子学相关标的，并说明自己更偏好集中持有一只 Win Semi。
先列几个： 2455 TWSE：Visual Photonics 268A TSEJ：Rigaku 3017 TWSE：Asial Vital 3363 TEPX：Foci 3450 TWSE：Elite Advanced Laser 5289 TPEX：Innodisk 6451 TWSE：Shunsin 6777 TSEJ：Santek 我通常会更专注于像 Win Semi（3105 TPEX）这样我最有把握的一只，做更简单、更集中的配置。
英文原文
Just a few: 2455 TWSE: Visual photonics 268A TSEJ: Rigaku 3017 TWSE: Asial Vital 3363 TEPX: Foci 3450 TWSE: Elite Advanced Laser 5289 TPEX: Innodisk 6451 TWSE: Shunsin 6777 TSEJ: Santek I usually try and focus on one like Win Semi (3105 TPEX) that I have the most concentration in and do more simpler concentrated on those.